Humanin

Preclinical
Anti-Aging & Skin
Humanin

A mitochondrial-derived peptide with powerful cytoprotective effects that protects against age-related diseases and cellular stress.

Administration

Subcutaneous injection

Dosage Range

1-5 mg weekly (research dosing)

Mechanism of Action

Humanin binds to IGFBP-3 and BAX, inhibiting apoptosis and protecting cells from oxidative stress. It activates STAT3 signaling and reduces amyloid-beta toxicity, providing broad cytoprotective effects.

Clinical Benefits

Powerful cytoprotection
Reduces Alzheimer's pathology
Protects against oxidative stress
Supports cardiovascular health
Anti-aging at cellular level

Clinical Evidence

Discovered in 2001 from Alzheimer's patient brain tissue. Extensive preclinical evidence for neuroprotection, cardioprotection, and metabolic improvement. Circulating levels correlate with longevity in centenarian studies.

Side Effects

Injection site reaction
Mild nausea
Headache (rare)

Contraindications

Active cancer
Pregnancy
Autoimmune conditions

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapy should only be administered under the supervision of a qualified healthcare provider. Always consult your physician before starting any new treatment protocol.